Bridging the Regulatory Divide: Ensuring Safety and Equity in Wearable Health Technologies

As wearable devices increasingly straddle the line between consumer wellness tools and regulated medical devices, a new regulatory framework is urgently needed to safeguard both safety and equity.

</div>

The Blurred Frontier: Wellness vs. Medical Devices

The August 27, 2025 study “Bridging the Regulatory Divide” highlights a growing problem: many wearable health tools now operate in a grey area between consumer wellness and regulated medical devices . Features like sleep tracking or heart‑rate monitoring may bypass clinical validation, yet are frequently repurposed for medical decisions—raising safety concerns and undermining public trust . This ambiguity stems from regulatory definitions that haven’t kept pace with technological advances.

FDA’s 2026 Guidance: Expanding the Wellness Exemption

In January 2026, the FDA issued updated guidance clarifying how it interprets the distinction between general wellness products and medical devices . It reaffirmed that non‑invasive wearables—like heart‑rate monitors or sleep trackers—may remain exempt from medical device regulation if they pose low risk and avoid clinical claims . This expansion includes devices estimating blood pressure or oxygen saturation, provided they lack claims of diagnosis, treatment, or clinical action .